<DOC>
	<DOCNO>NCT01379846</DOCNO>
	<brief_summary>The purpose study evaluate efficacy ( immunogenicity ) TAK-816 administer healthy Japanese infant multiple subcutaneous dos .</brief_summary>
	<brief_title>Study TAK-816 Healthy Infants</brief_title>
	<detailed_description>Haemophilus Influenzae type b ( Hib ) one major cause infectious meningitis child , also cause sepsis , cellulitis , arthritis , epiglottitis , pneumonia myelitis . TAK-816 conjugate Hib vaccine test healthy infant age 3-6 month time first dose . The objective study evaluate efficacy ( immunogenicity ) safety TAK-816 ( 10 ϻg/0.5 mL ) comparison ActHIB ( Haemophilus b Conjugate Vaccine ) control . In addition , efficacy ( immunogenicity ) safety Absorbed Diphtheria-Purified Pertussis-Tetanus Combined ( DPT-TAKEDA ) vaccine TAK-816 DPT vaccine administer concomitantly also investigate . For Primary Immunization Phase study : three dose TAK-816 ActHIB 10 µg/0.5 mL DPT-TAKEDA 0.5 mL administer 4-week interval 8 week ( Visit 1 , 2 , 3 ) . At4 week third dose , follow-up observation evaluation make ( Visit 4 ) . For Booster Vaccination Phase study : single dose TAK-816 ActHIB 10 µg/0.5 mL DPT-TAKEDA 0.5 mL give 52 week third dose ( Visit 5 ) . At 4 week fourth dose , follow-up observation evaluation make ( Visit 6 ) .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Male female infant age ≥3 &lt; 7 month ( exclude hospitalize infant ) . 2 . Infants whose legal acceptable representative give informed consent study prior enrollment . 3 . Infants whose parent legal guardian agree cooperate investigator study period . 1 . Any serious acute illness . 2 . Any underlying cardiovascular , renal , hepatic , hematologic disease , and/or developmental disorder . 3 . History possible Haemophilus influenzae type b ( Hib ) infection . 4 . History possible pertussis , diphtheria tetanus infection . 5 . Previously diagnosed immunodeficiency . 6 . A documented history anaphylaxis ingredient investigational product ( TAK816 , ActHIB DPTTAKEDA ) . 7 . A history convulsion . 8 . Previous administration another Hib vaccine . 9 . Previous administration vaccine contain component polio , diphtheria , pertussis , tetanus . 10 . Treatment live vaccine 27 day first dose TAK816 inactivate vaccine 6 day dose .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Immunostimulation</keyword>
	<keyword>Haemophilus b conjugate vaccine</keyword>
	<keyword>HIB</keyword>
</DOC>